Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Intra-abdominal pressure reflects the bladder pressure or pressure inside the abdominal compartment and is usually measured via a urinary catheter. It is used to identify the risk of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS). The condition associated with this syndrome is major fluid resuscitation, severe gut edema or intestinal obstruction or ascites. Normal intra-abdominal pressure is 0 - 5 mmHg.
The global intra-abdominal pressure measurement devices market size is estimated to be valued at US$ 68.2 million in 2020 and is expected to exhibit a CAGR of 16.1% over the forecast period (2020-2027).
Figure 1. Global Intra-abdominal Pressure Measurement Devices Market Share (%), by Product Type, 2020
Development of Di-(2-ethylhexyl) phthalate (DEHP)-free products is expected to propel growth of the global intra-abdominal pressure measurement devices market over the forecast period. DEHP is commonly used in the medical devices industry as a plasticizer for various plastic materials to make plastic flexible. Use of these phthalates in the device/disposable manufacturing process may inhibit testosterone production in the adult human testis and affect reproductive health. Therefore, market players are focused on offering alternatives to DHEP such as DEHT (Di-(2-ethylhexyl) terephthalate), which is not genotoxic and does not cause reproductive toxicity. For instance, ConvaTec Inc. offers its major continence & critical care brands that are DEHP-free. This includes the flexi-seal fecal management system and the abviser autovalve intra-abdominal pressure monitoring devices.
Global Intra-abdominal Pressure Measurement Devices Market – Impact of Coronavirus (Covid-19) Pandemic
Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 25.6 million infected individuals worldwide as of September 3rd 2020.
The demand for intra-abdominal pressure measurement devices significantly increased during the coronavirus pandemic, as COVID-19 patients have developed severe symptoms and resulted in mortality, in which intra-abdominal pressure measurement devices are used to monitor vital signs.
Moreover, various healthcare regulatory authorities have issued guidelines for patients who require critical care during the COVID-19 pandemic. On March 20, 2020, National Institute for Clinical Excellence (NICE) issued the guidelines to maximize the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection.
Intra-abdominal Pressure Measurement Devices Market Report Coverage
||Market Size in 2019:
||US$ 68.2 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 193.7 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of the Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product Type: Disposables, Equipment.
- By Application: Intra-abdominal Hypertension, Intra-compartment Pressure.
- By End User: Hospitals, Trauma Centers, Ambulatory Surgical Centers (ASCs), Clinics.
CR. Bard, Inc. (Becton, Dickinson and Company), ConvaTec Group PLC, Stryker Corporation, Biometrix Ltd. (Degania Silicone, Ltd.), Centurion Medical Products (Medline Industries, Inc.), and Potrero Medical
- Development of Di-(2-ethylhexyl) phthalate (DEHP)-free devices
- High prevalence of intra-abdominal hypertension and intra-compartment pressure among the patients admitted in ICU
|Restraints & Challenges:
- Complications associated with pressure measurement devices
- Product recalls
Global Intra-Abdominal Pressure Measurement Devices Market: Restraints
Complications associated with the procedures are expected to hinder growth of the global intra-abdominal pressure measurement devices market. Intra-abdominal pressure is generally measured via a patient’s bladder. Some of the major problems associated with pressure management devices include bladder infection and needle stick injuries that may cause patient discomfort and raise compliance risks.
Although there have been several publications in the recent past, IAP measurement techniques and clinical applicability have not been fully established to date. Intravesical IAP measurement is a consensus. However, there are challenges regarding zero-reference point, infusion volume, measurement frequency, and indications. Such scenario is also expected to hinder growth of the market.
Figure 2. Global Intra-abdominal Pressure Measurement Devices Market Value (US$ Mn), by Region, 2020
North America region is expected to hold dominant position in the global intra-abdominal pressure measurement devices market, owing to increasing number of product approvals associated with intra-abdominal pressure measurement by regulatory bodies. For instance, in April 2016, Potrero Medical, Inc. received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for Accuryn Monitoring System, a next-generation diagnostic tool, which provides accurate intra-abdominal pressure (IAP) and real-time urine output (UO).
The increasing number of admissions in critical care units in Europe is expected to drive growth of the Europe intra-abdominal pressure measurement devices market over the forecast period. According to the Annual Quality Report 2018/19 for adult critical care by Intensive Care National Audit And Research Centre, around 224,748 admissions in 263 National Health Service adult critical care unit(s) in England, Wales, and Northern Ireland were reported during the period April 1, 2018 to March 31, 2019.
Major players operating in the global intra-abdominal pressure measurement devices market include CR. Bard, Inc. (Becton, Dickinson and Company), ConvaTec Group PLC, Stryker Corporation, Biometrix Ltd. (Degania Silicone, Ltd.), Centurion Medical Products (Medline Industries, Inc.), and Potrero Medical.